Lyell Immunopharma, Inc. (LYEL) has 46 open-market insider trades by 14 insiders since 2021. Over the last six months insiders net sold $256K. The most active filer is Lynn Seely, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Paul L. Berns | 10% | — | 1 | $12.5M | 2026-03-06 |
| ARCH Venture Partners IX Overage, L.P. | 10% | — | 1 | $12.5M | 2026-03-06 |
| Lynn Seely | CEOPres | — | 9 | $621K | 2026-08-21 |
| Richard Klausner | Dir | — | 3 | $430K | 2025-03-14 |
| Cathy Friedman | Dir | — | 1 | $300K | 2021-12-14 |
| Charles W. Newton | CFO | — | 3 | $242K | 2025-08-21 |
| Sumant Ramachandra | Dir | — | 1 | $232K | 2025-03-21 |
| Veronica Sanchez Bulis | VPController | — | 5 | $97K | 2026-08-10 |
| Gary K. Lee | CSO | — | 8 | $90K | 2026-08-21 |
| Stephen J. Hill | COO | — | 8 | $64K | 2026-08-21 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jarrad Mattieu Aguirre | — | Sell | $4K | 2026-10-12 |
| David Shook | — | Sell | $6K | 2026-09-10 |
| Gary K. Lee | CSO | Sell | $23K | 2026-08-21 |
| Lynn Seely | CEO & President | Sell | $149K | 2026-08-21 |
| Stephen J. Hill | COO | Sell | $15K | 2026-08-21 |
| Stephen J. Hill | COO | Sell | $1K | 2026-08-10 |
Companies that share insiders with LYEL, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Veronica Sanchez Bulis | VP & Controller | Sell | $9K | 2026-08-10 |
| Gary K. Lee | CSO | Sell | $2K | 2026-08-10 |
| Lynn Seely | CEO & President | Sell | $6K | 2026-08-10 |
| Innovative Cellular Therapeutics Holdings Ltd | 10% Owner | Sell | $137 | 2026-07-17 |
| Innovative Cellular Therapeutics Holdings Ltd | 10% Owner | Sell | $137 | 2026-07-16 |
| David Shook | — | Sell | $25K | 2026-06-10 |
| Gary K. Lee | CSO | Sell | $2K | 2026-05-11 |
| Veronica Sanchez Bulis | VP & Controller | Sell | $4K | 2026-05-11 |
| Lynn Seely | CEO & President | Sell | $7K | 2026-05-11 |